Nucleoside analogs for treatment of the flaviviridae family of viruses and cancer
US10011629B2 · kind B2 · utility
0Cited by
0References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 27, 2016 |
| Grant date | Jul 3, 2018 |
| Priority date | — |
| Expiry date | Apr 27, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds, compositions and methods for treating or preventing Flaviviridae family of viruses (including HCV, Yellow fever, Dengue, Chikungunya and West Nile virus), RSV, HEV, and influenza infection and cancer in human subjects or other animal hosts.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.